Lucatelli, P., De Rubeis, G., Citone, M., Lucarelli, N.M., Pasqualini, V., Sturiale, M., et al. (2020) Heparin-Related Major Bleeding in Covid-19-Positive Patient: Perspective from the Outbreak. Cardiovascular and Interventional Radiology, 43, 1216-1217.
https://doi.org/10.1007/s00270-020-02532-3

has been cited by the following article:

• TITLE: Transcatheter Arterial Embolization as a Treatment for Life-Threatening Retroperitoneal Hemorrhage in COVID-19 Patients on Anticoagulant Therapy

  AUTHORS: Jovana Lalatović, Jelena Golubović, Matija Miljević, Filip Lukić, Sandra Jeličić, Nemanja Kraišnik, Aleksandra Aleksić, Zdravko Kalaba, Bojana Vidović, Borislav Tošković, Bogdan Crnokrak, Jovana Mrda, Marija Zdravković, Davor Mrda

  KEYWORDS: COVID-19, Retroperitoneal Hemorrhage, Lumbar Artery Bleeding, Transcatheter Arterial Embolization, Anticoagulant Therapy

  JOURNAL NAME: Open Journal of Emergency Medicine, Vol.9 No.4, December 14, 2021

  ABSTRACT: Retroperitoneal hemorrhage is a possible complication that has been noticed in COVID-19 patients on anticoagulant therapy. The data related to treatment and outcomes in this condition are scarce. We present a case series of four COVID-19 patients with lumbar artery bleeding, who were treated with transcatheter arterial embolization using embolization particles. The procedure was executed without any complications, and hemostasis was achieved in all four patients. Despite the patients survived the procedure, one patient died due to respiratory failure three weeks after the procedure, and one died due to hypovolemic shock two days later. Considering the ongoing state of COVID-19 pandemic, it is essential to be aware of transcatheter arterial embolization as a safe and effective procedure for treating retroperitoneal hemorrhage in COVID-19 patients.